Adaptimmune Therapeutics Plc (ADAPY)

0.0299 -0.01 (-14.57%) USD  |  OTCM  |  Dec 23, 16:00
More

Adaptimmune Therapeutics CAPEX To Revenue (TTM)

CAPEX To Revenue (TTM) Chart

View CAPEX To Revenue (TTM) for ADAPY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View CAPEX To Revenue (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

CAPEX To Revenue (TTM) Range, Past 5 Years

View CAPEX To Revenue (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

CAPEX To Revenue (TTM) Benchmarks

View CAPEX To Revenue (TTM) Benchmarks
Start Trial
Biodexa Pharmaceuticals Plc --
NuCana Plc --
Autolus Therapeutics Plc Upgrade
Mereo BioPharma Group Plc Upgrade
Bicycle Therapeutics Plc Upgrade